BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2659597)

  • 1. Expression and initial characterization of a recombinant human thrombospondin heparin binding domain.
    Yabkowitz R; Lowe JB; Dixit VM
    J Biol Chem; 1989 Jun; 264(18):10888-96. PubMed ID: 2659597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein.
    Mikhailenko I; Krylov D; Argraves KM; Roberts DD; Liau G; Strickland DK
    J Biol Chem; 1997 Mar; 272(10):6784-91. PubMed ID: 9045712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human neutrophils increases thrombospondin receptor expression.
    Suchard SJ; Boxer LA; Dixit VM
    J Immunol; 1991 Jul; 147(2):651-9. PubMed ID: 1712815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and analysis of COOH-terminal deletions of the human thrombospondin molecule.
    Prochownik EV; O'Rourke K; Dixit VM
    J Cell Biol; 1989 Aug; 109(2):843-52. PubMed ID: 2760115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin.
    Legrand C; Morandi V; Mendelovitz S; Shaked H; Hartman JR; Panet A
    Arterioscler Thromb; 1994 Nov; 14(11):1784-91. PubMed ID: 7947604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel monoclonal antibody (V58A4) raised against a recombinant NH2-terminal heparin-binding fragment of human endothelial cell thrombospondin.
    Morandi V; Edelman L; Legrand YJ; Legrand C
    FEBS Lett; 1994 Jun; 346(2-3):156-60. PubMed ID: 8013625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human carcinoma cells express receptors for distinct domains of thrombospondin.
    Yabkowitz R; Dixit VM
    Cancer Res; 1991 Mar; 51(6):1645-50. PubMed ID: 1705477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding and degradation of thrombospondin-1 mediated through heparan sulphate proteoglycans and low-density-lipoprotein receptor-related protein: localization of the functional activity to the trimeric N-terminal heparin-binding region of thrombospondin-1.
    Chen H; Sottile J; Strickland DK; Mosher DF
    Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):959-63. PubMed ID: 8836144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.
    Adams JC; Lawler J
    Mol Biol Cell; 1994 Apr; 5(4):423-37. PubMed ID: 7519904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity.
    Murphy-Ullrich JE; Gurusiddappa S; Frazier WA; Höök M
    J Biol Chem; 1993 Dec; 268(35):26784-9. PubMed ID: 8253815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin stimulates motility of human neutrophils.
    Mansfield PJ; Boxer LA; Suchard SJ
    J Cell Biol; 1990 Dec; 111(6 Pt 2):3077-86. PubMed ID: 2269666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminus of thrombospondin: the domain stands apart.
    Elzie CA; Murphy-Ullrich JE
    Int J Biochem Cell Biol; 2004 Jun; 36(6):1090-101. PubMed ID: 15094124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet thrombospondin interactions with human high and low molecular weight kininogens.
    DeLa Cadena RA; Wyshock EG; Kunapuli SP; Schultze RL; Miller M; Walz DA; Colman RW
    Thromb Haemost; 1994 Jul; 72(1):125-31. PubMed ID: 7974360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of truncated amino-terminal trimers of thrombospondin.
    Sottile J; Selegue J; Mosher DF
    Biochemistry; 1991 Jul; 30(26):6556-62. PubMed ID: 2054354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of two binding domains for thrombospondin within fibronectin.
    Zafar RS; Zeng Z; Walz DA
    Arch Biochem Biophys; 1992 Sep; 297(2):271-6. PubMed ID: 1497347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor.
    Yabkowitz R; Dixit VM
    Cancer Res; 1991 Jul; 51(14):3648-56. PubMed ID: 1712244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human thrombospondin-4.
    Lawler J; McHenry K; Duquette M; Derick L
    J Biol Chem; 1995 Feb; 270(6):2809-14. PubMed ID: 7852353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single chain 19-kDa fragment from bovine thrombospondin binds to type V collagen and heparin.
    Takagi J; Fujisawa T; Usui T; Aoyama T; Saito Y
    J Biol Chem; 1993 Jul; 268(21):15544-9. PubMed ID: 8340381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis of thrombospondin during cathepsin-G-induced platelet aggregation: functional role of the 165-kDa carboxy-terminal fragment.
    Rabhi-Sabile S; Pidard D; Lawler J; Renesto P; Chignard M; Legrand C
    FEBS Lett; 1996 May; 386(1):82-6. PubMed ID: 8635609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a cDNA encoding the heparin and collagen binding domains of human thrombospondin.
    Dixit VM; Hennessy SW; Grant GA; Rotwein P; Frazier WA
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5449-53. PubMed ID: 3461443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.